Delivery Order 36F79721D0141-36C24526N0111
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Recordati Rare Diseases Inc. was awarded a delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor LAR 30 mg and 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The potential value of this firm fixed price order is $21,623.35 to be performed at a place of performance in Bartlett, Tennessee by January 31, 2024. Recordati holds two key indefinite-delivery vehicles for supplying...
- This is a federal delivery order awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer specializing in rare disease treatments. The $22,438.42 fixed-price contract is for the supply of Signifor LAR 40 mg, a medication used to treat conditions such as Cushing's disease and acromegaly. The delivery order was placed under the Pharmaceuticals and Drugs Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor, Recordati Rare Diseases Inc. Division, will deliver the pharmaceutical to a facility in Bartlett, Tennessee to support VHA's Veterans Integrated Service Network 5. The firm fixed price order runs from October 20th through the 24th of 2023. The contract utilizes...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor will deliver the drug to a facility in Bartlett, Tennessee within the period of performance from October 11-13, 2023. Recordati Rare Diseases, Inc. will perform as the prime contractor under this firm fixed price contract issued by VA-VHA Network 5 to support its...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $22,438.42 contract is for the drug SIGNIFOR LAR 40 MG and is part of the company's broader Federal Supply Schedule (FSS-61-IB) contract with the VA, valued at $15.6 million, as well as a $3,156,115 Blanket Purchase Agreement covering multiple rare disease treatments. The award has no set-aside...
- The U.S. Department of Veterans Affairs (VA) awarded a $21,622.48 firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer specializing in rare disease treatments. This order is placed against Recordati's five-year, $15.6 million Federal Supply Schedule (FSS-61-IB) contract, which allows the VA to procure the company's full range of orphan drugs and specialty pharmaceuticals. The current delivery order is for Signifor LAR 40 mg, used...
- The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract worth $10,811.24 to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group. The contract is for the supply of Signifor LAR 40 MG, a treatment for Cushing's disease and acromegaly. This award is associated with Recordati's larger, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, as well as a $3.1 million Blanket Purchase Agreement (BPA) for a range of...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $22,438.42, is for the supply of Signifor LAR 40 mg, an orphan drug used to treat rare medical conditions. The contract was awarded under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, and has an ultimate completion date of April 8, 2025. The...
- This federal contract award is for the delivery of Signifor LAR (pasireotide) 30 mg and 40 mg to the U.S. Department of Veterans Affairs (VA). The contract, valued at $21,622.48, was awarded to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer that specializes in rare disease treatments. The contract is a delivery order placed against Recordati's existing Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of Signifor LAR 40 mg, a rare disease medication, with a ceiling value of $22,438.42 and a period of performance ending on July 7, 2025. The award is placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does...